Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Related Articles by Review for PubMed (Select 20445812)

1.

Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).

Simari RD, Moyé LA, Skarlatos SI, Ellis SG, Zhao DX, Willerson JT, Henry TD, Pepine CJ.

J Cardiovasc Transl Res. 2010 Feb;3(1):30-6. doi: 10.1007/s12265-009-9160-3.

2.

Strategies for more rapid translation of cellular therapies for children: a US perspective.

Sanchez R, Silberstein LE, Lindblad RW, Welniak LA, Mondoro TH, Wagner JE.

Pediatrics. 2013 Aug;132(2):351-8. doi: 10.1542/peds.2012-3383. Epub 2013 Jul 8. Review.

3.

Dr. Sonia Skarlatos and the National Heart, Lung, and Blood institute translational research and resource programs.

McDonald CL.

Hum Gene Ther. 2013 Nov;24(11):899-905. doi: 10.1089/hum.2013.2511. Review.

4.

Bone marrow stem cells for the treatment of ischemic heart disease: a clinical trial review.

Fuh E, Brinton TJ.

J Cardiovasc Transl Res. 2009 Jun;2(2):202-18. doi: 10.1007/s12265-009-9095-8. Epub 2009 Mar 17. Review.

PMID:
20559989
5.

Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network.

Denlinger LC, Sorkness CA, Chinchilli VM, Lemanske RF Jr.

J Allergy Clin Immunol. 2007 Jan;119(1):3-11; quiz 12-3. Epub 2006 Dec 4. Review.

6.

Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies.

Reed W, Noga SJ, Gee AP, Rooney CM, Wagner JE, McCullough J, McKenna DH, Whiteside TL, Donnenberg AD, Baker AK, Lindblad RW, Wagner EL, Mondoro TH.

Transfusion. 2009 Apr;49(4):786-96. doi: 10.1111/j.1537-2995.2008.02027.x. Epub 2008 Dec 23. Review.

7.

Cell therapy for left ventricular dysfunction: an overview for cardiac clinicians.

Chong JJ.

Heart Lung Circ. 2012 Sep;21(9):532-42. doi: 10.1016/j.hlc.2012.04.020. Epub 2012 May 31. Review.

PMID:
22658631
8.

Asthma Clinical Research Network: lessons learned.

Craig T, Quinn L.

Mt Sinai J Med. 2011 Sep-Oct;78(5):671-82. doi: 10.1002/msj.20282. Review.

PMID:
21913198
9.

Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012.

Matthay MA, Anversa P, Bhattacharya J, Burnett BK, Chapman HA, Hare JM, Hei DJ, Hoffman AM, Kourembanas S, McKenna DH, Ortiz LA, Ott HC, Tente W, Thébaud B, Trapnell BC, Weiss DJ, Yuan JX, Blaisdell CJ.

Am J Respir Crit Care Med. 2013 Aug 1;188(3):370-5. doi: 10.1164/rccm.201303-0522WS. Review.

10.

Overview of the Consortium of Hospitals Advancing Research on Tobacco (CHART).

Riley WT, Stevens VJ, Zhu SH, Morgan G, Grossman D.

Trials. 2012 Aug 1;13:122. doi: 10.1186/1745-6215-13-122. Review.

11.

Recovery from heart failure with circulatory assist: a working group of the National, Heart, Lung, and Blood Institute.

Reinlib L, Abraham W; Working Group of the National, Heart, Lung, and Blood Institute.

J Card Fail. 2003 Dec;9(6):459-63. Review.

PMID:
14966786
12.

Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis.

Zhao Q, Ye X.

Expert Opin Biol Ther. 2011 Dec;11(12):1569-79. doi: 10.1517/14712598.2011.616491. Epub 2011 Oct 8. Review.

PMID:
21981749
13.

Stem cells for myocardial repair.

Siu CW, Liao SY, Liu Y, Lian Q, Tse HF.

Thromb Haemost. 2010 Jul;104(1):6-12. doi: 10.1160/TH09-05-0336. Epub 2010 Mar 29. Review.

PMID:
20352151
14.

Stem cells and cardiac repair: a critical analysis.

Dinsmore JH, Dib N.

J Cardiovasc Transl Res. 2008 Mar;1(1):41-54. doi: 10.1007/s12265-007-9008-7. Epub 2008 Jan 31. Review.

PMID:
20559957
15.

Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells.

Zenovich AG, Davis BH, Taylor DA.

Handb Exp Pharmacol. 2007;(180):117-65. Review.

PMID:
17554507
16.

An overview of the optimal planning, design, and conduct of phase I studies of new therapeutics.

LoRusso PM, Boerner SA, Seymour L.

Clin Cancer Res. 2010 Mar 15;16(6):1710-8. doi: 10.1158/1078-0432.CCR-09-1993. Epub 2010 Mar 9. Review.

17.

The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases.

Goss CH, Mayer-Hamblett N, Kronmal RA, Ramsey BW.

Adv Drug Deliv Rev. 2002 Dec 5;54(11):1505-28. Review.

PMID:
12458158
18.

[Surgical intramyocardial stem cell therapy for chronic ischemic heart failure].

Kaminski A, Donndorf P, Klopsch C, Steinhoff G.

Herz. 2010 Aug;35(5):324-33. doi: 10.1007/s00059-010-3354-y. Review. German.

PMID:
20625690
19.

Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program.

Goldberg RM, Sargent DJ, Morton RF, Mahoney MR, Krook JE, O'Connell MJ.

J Clin Oncol. 2002 Dec 1;20(23):4591-6. Review.

PMID:
12454117
20.

Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program.

Minasian LM, Carpenter WR, Weiner BJ, Anderson DE, McCaskill-Stevens W, Nelson S, Whitman C, Kelaghan J, O'Mara AM, Kaluzny AD.

Cancer. 2010 Oct 1;116(19):4440-9. doi: 10.1002/cncr.25248. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk